Press Room

ISPE Annual Meeting

Start
Sunday, October 15, 2023
End
Wednesday, October 18, 2023
Location: Las Vegas, USA

ISPE Annual Meeting offers the opportunity to engage in industry-critical conversations. A comprehensive education program provides attendees with technical sessions on the latest developments in supply chain, operations, facilities, equipment, information systems, product development, production systems, quality systems, regulatory guidance and cutting-edge industry innovations.

On October 17 (11am) Anthony Tantuccio, Fellow Scientist at Hovione, is hosting a presentation on “Continuous Tableting Control Strategies: When and How to Apply Them” where he will share key considerations about appropriate control strategies in CT and how Hovione is positioning itself to enable them. This presentation is included on the topic “Advancements in Drug development and Equipment design”.

Session description:
A CDMO’s role is particularly critical for the adoption of CM in that an equipment standard needs to be established where most of the industry can seamlessly integrate with their own development, manufacturing, and supply chains.

The processes and knowledge of owning and operating the technology must be broad, yet robust, to assure that the benefits outweigh the perceived risks by a meaningful margin. Equally important and fundamental is the control strategy, which provides the final assurance that the chosen manufacturing process is fit for the intended product and will provide the desired quality. It is the fundamental component which is the most challenging to standardize because the drug pipelines are constantly evolving, and demand volumes are volatile these days.

This means it is not possible to have a one-size-fits-all control strategy, that depending on the product lifecycle and the nature of the formulation, the control strategy too may need to be flexible and evolve. This talk will focus on the key themes pertinent to the robust and pragmatic continuous tableting control strategies which Hovione is positioning itself to offer and deploy.

Contact our experts today to find out more aboutContinuous Tableting at Hovione.

Find out more about ISPE 
 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025